NASDAQ:DMTX Shareholder Alert: Investigation of Takeover of Dimension Therapeutics Inc
An investigation on behalf of investors, who currently hold NASDAQ:DMTX shares, was announced concerning whether the takeover of Dimension Therapeutics Inc by REGENXBIO Inc for a value of approximately $3.41 per share is unfair.
View full press release